Recalls / Active ingredient / Trandolapril
Trandolapril
1 FDA drug recall involving the active ingredient “Trandolapril”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-08-14 | Class III | Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Ma | Glenmark Pharmaceuticals Inc., USA |